Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$11.02 USD
-0.05 (-0.45%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $11.04 +0.02 (0.18%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth C Momentum A VGM
Pediatrix Medical Group (MD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$9.43 | $10.50 | $8.00 | -14.81% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Pediatrix Medical Group comes to $9.43. The forecasts range from a low of $8.00 to a high of $10.50. The average price target represents a decline of 14.81% from the last closing price of $11.07.
Analyst Price Targets (7 )
Broker Rating
Pediatrix Medical Group currently has an average brokerage recommendation (ABR) of 2.88 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.88 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, one is Strong Buy, representing 12.5% of all recommendations. A month ago, Strong Buy represented 12.5%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MD.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | Truist Securities | David S Macdonald | Hold | Hold |
8/9/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
8/9/2024 | UBS | Aj Rice | Hold | Hold |
8/6/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
5/5/2024 | SVB Securities | Whit Mayo | Hold | Hold |
3/6/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.88 |
ABR (Last week) | 2.88 |
# of Recs in ABR | 8 |
Average Target Price | $9.43 |
LT Growth Rate | 5.40% |
Industry | Medical Services |
Industry Rank by ABR | 149 of 253 |
Current Quarter EPS Est: | 0.37 |